| [2] Eisenhauer EA,Therasse P,Bogaerts J,et al.New response evaluation criteria in solid tumor:revised RECIST guideline(version 1.1)[J].Eur J of Cancer,2009,45(2):228. | |
| [2] | 金懋林.消化道恶性肿瘤的化学治疗[M].北京:北京大学出版社,2008:229. |
| [3] 孙燕,石远凯.临床肿瘤内科治疗手册[M].北京:人民卫生出版社,2008:152-153. | |
| [4] Mukherjee S,Bandyopadhyay G,Dutta C,et al.Evaluation of endoscopic biopsy in gastric lesions with aspecial reference to the significance of mast cell density[J].Indian J Pathol Microbiol,2009,52(1):20-24. | |
| [5] Wagner AD,Grothe W,Kleber G,et al.Chemotherapy for advanced gastric cancer[J].Cochrane Library,2005,18(2):357-365. | |
| [6] 储大同.当代肿瘤内科治疗方案评价[M].北京:北京大学医学出版社,2010:146. | |
| [7] Yamada Y,Shirao K,Ohtsu A,et al.Phase Ⅱ trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions[J].Annals Oncology,2001,12(7):1133-1137. | |
| [8] Gadgeel SM,Shields AF,Heilbrun LK,et al.Phase Ⅱ study of paclitaxel and carboplatin in patients with advanced gastric cancer[J].Am J Clin Oncol,2003,26(1):37-41. | |
| [9] 周小宁,陈苏容.TCF方案治疗晚期胃癌的临床观察[J].实用肿瘤学杂志,2007,21(6):536-538. | |
| [10] 王海存.紫杉醇联合5-氟尿嘧啶治疗进展期胃癌临床研究[J].医学信息:中旬刊,2010(3):498-499. |